Schouten et al. [40] applied the same methodological approach as Joosse et al. [22,24] to develop two HRD tests that were specific for ovarian cancer, the Ovarian cancer BRCA1-like classifier and Ovarian cancer BRCA2-like classifier, which both are based on copy numbers as input. This evidence concerns the gene BRCA1 and ovarian carcinoma.